Latest News about VYNE
Recent news which mentions VYNE
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
From Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
From Benzinga
VYNE Therapeutics Offloads Its Topical Minocycline Assets To Journey Medical In $450M+ Deal
January 13, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
From Benzinga
50 Biggest Movers From Friday
December 13, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
From Benzinga
36 Stocks Moving In Friday's Mid-Day Session
December 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
From Benzinga
18 Stocks Moving in Friday's Pre-Market Session
December 10, 2021
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
From Benzinga
GCP Stock: The Big Buyout News That Has GCP Applied Technologies Bounding Higher Today
December 06, 2021
From InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
December 06, 2021
From Benzinga
Restaurant Stocks: What’s Going on With TACO, DIN, CAKE, MCD, BJRI and FRGI Today?
December 06, 2021
From InvestorPlace
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 06, 2021
From Benzinga
From InvestorPlace
VYNE Therapeutics's Return On Capital Employed Insights
November 11, 2021
Tickers
VYNE
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 04, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 26, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 07, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
Looking Into VYNE Therapeutics's Return On Capital Employed
October 01, 2021
Tickers
VYNE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.